Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Mexico for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Mexico only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Mexico (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Frank Wyant (NPI 1497740989)

Field	Value
Entity Type	Individual
Organization	Frank Wyant
Address	806 Dr. Mlk Jr. Ave., Ne
City	Albuquerque
State	NM
ZIP	87102
Taxonomy	Ophthalmology Physician
NPI Enumerated	September 12, 2005

Payer Source	Total Paid
Medicare	$509.3K
Medicaid	$0

Key Findings

This provider’s Medicare billing is highly concentrated: the precomputed top 3 Medicare codes by revenue account for 88.6% of this provider's total Medicare revenue, with J0178 alone generating $341K (67.1% of Medicare revenue). Such concentration indicates the practice derives the large majority of Medicare receipts from a very small set of drug-administration codes.

Code mix and descriptions point to a retina-focused procedural practice. The top three codes are J0178 (aflibercept), J2777 (faricimab-svoa), and J2778 (ranibizumab) — all intravitreal injections — which, together with vitreous injection procedure 67028 ($29.6K, 5.8%), indicate routine, repeated anti-VEGF therapy and associated ocular injection procedures as the core service line.

The revenue profile is driven by drug and procedure payments rather than evaluation-and-management visits: 99214 accounts for $11.6K (2.3%) and 99213 for $2.2K (0.4%) of Medicare revenue, while intravitreal drug codes dominate overall receipts. This suggests the practice’s financial model depends primarily on administered ophthalmic pharmaceuticals and injection procedures rather than office E/M volume.

This provider is effectively single-payer from the claims we have: total Medicare revenue is $509.3K and there is no Medicaid billing on file. The absence of Medicaid activity implies the practice’s public-payer footprint is concentrated in Medicare.

National competitive standing for the top drug codes is modest: J0178 ranks #1943 of 3204 providers (39th percentile) and is described as "typical, unremarkable volume," J2777 ranks #1920 of 2039 (6th percentile, "typical, unremarkable volume"), and J2778 ranks #1065 of 1208 (12th percentile, "typical, unremarkable volume"). These ranks indicate the provider is not a dominant national outlier on these injectables and generally reports volumes that peer comparisons label as typical or unremarkable.

There is relatively stronger use of diagnostic retinal imaging compared with many peers: 92134 generated $5.8K (1.1% of Medicare revenue) and ranks #5856 of 26868 providers nationally (78th percentile, described as "typical, unremarkable volume"). This higher percentile suggests a comparatively greater reliance on retinal imaging in support of therapeutic injections.

Secondary revenue lines are present but small: 67028 produced $29.6K (5.8%) with 394 claims, and J7999 (compounded drug, not otherwise classified) produced $7.9K (1.5%) with 131 claims. These entries show supplementary procedural and compounded-drug billing, but neither comes close to the revenue dominance of J0178 and the other top injectables.

The provider has long tenure on file, with NPI enumeration on 2005-09-12 (~21 years ago), which aligns with an established ophthalmology practice profile that centers on repeated intravitreal treatments. Combined with the concentrated drug/procedure revenue mix, the tenure supports the interpretation of a stable, procedure-focused ophthalmology practice rather than a recently opened or rapidly evolving operation.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

9 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	490	$700	$341K
J2777	Injection, faricimab‑svoa, 0.1 mg	2,400	$30	$67.2K
J2778	Injection, ranibizumab, 0.1 mg	230	$180	$42.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	390	$80	$29.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	150	$80	$11.6K
J7999	Compounded drug, not otherwise classified	130	$60	$7.9K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	240	$20	$5.8K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	60	$40	$2.2K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	10	$90	$1K

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 9 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Mexico Distribution

Frank Wyant — 0 of 9 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Mexico

Full comparison — all codes billed, vs. state median

9 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	11	20	1,100	$690	$816.1K
J2777	14	20	17,340	$30	$653.4K
J2778	11	10	720	$180	$247.3K
67028	13	30	390	$90	$71.6K
J7999	9	10	320	$60	$18.6K
99214	928	2,700	90	$70	$12.9K
99213	1,290	2,440	60	$50	$7.3K
92134	35	160	70	$30	$5.9K
99204	1,158	1,210	30	$100	$4.5K

Related Providers

Other providers that share a Tax Identification Number (TIN) with Frank Wyant, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Eye Associates Of New Mexico Ltd	NM	Ophthalmology Physician	$0	$46.9M
John Pitcher	NM	Ophthalmology Physician	$5.1M	$0
Mark Chiu	NM	Ophthalmology Physician	$3.8M	$0
Christopher Roybal	NM	Ophthalmology Physician	$3.8M	$0
Richard Kinsey	TN	Anatomic Pathology & Clinical Pathology Physician	$3.3M	$147.3K
Ashok Reddy	NM	Ophthalmology Physician	$3.2M	$0
Mark Carmichael	CA	Hematology & Oncology Physician	$3.1M	$0
Howard Martin	TX	Dermatopathology (Pathology) Physician	$3M	$0
Kamalesh Ramaiya	NM	Ophthalmology Physician	$2.9M	$0
Daniel Kasuga	TX	Retina Specialist (Ophthalmology) Physician	$2.9M	$0

Nearby Providers

Other providers in the same ZIP code as Frank Wyant, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Tricore Reference Laboratories	NM	Clinical Medical Laboratory	$0	$64.8M
Bright Horizons, Inc.	NM	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$46.9M
Lovelace Health System LLC	NM	General Acute Care Hospital	$0	$45.2M
Tricore Inc.	NM	Clinical Medical Laboratory	$7M	$35.8M
App Of New Mexico Ed PLLC	NM	Emergency Medicine Physician	$0	$42M
Duke City Recovery Toolbox LLC	NM	Community/Behavioral Health Agency	$108.4K	$28M
Metro Treatment Of New Mexico LP	NM	Methadone Clinic	$220.4K	$27.9M
Enchanted Care Solutions, LLC	NM	Home Health Agency	$0	$25.8M
Open Skies Healthcare	NM	Community/Behavioral Health Agency	$0	$23.8M
Krossroads Integrative Health And Recovery Solutions Inc	NM	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$16.7M

Frank Wyant — Billing Profile & Reimbursement Data

Sign up for Frank Wyant — Billing Profile & Reimbursement Data policy alerts

Frank Wyant — Billing Profile & Reimbursement Data

Sign up for Frank Wyant — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References